Loading
Latest filing published 16 Mar 2020 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €25k.
No signal scores available.
Our data holds just one disclosure by Thomas Ross Sr., dated 16 March 2020, reporting an open-market purchase worth €25k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Further filings will be added here. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration